HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pedro Esbrit Selected Research

parathyroid hormone-related protein (107-111)

6/2013Src kinases mediate VEGFR2 transactivation by the osteostatin domain of PTHrP to modulate osteoblastic function.
7/2012Osteostatin-loaded onto mesoporous ceramics improves the early phase of bone regeneration in a rabbit osteopenia model.
10/2011Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pedro Esbrit Research Topics

Disease

6Acute Kidney Injury (Acute Renal Failure)
10/2019 - 01/2004
6Bone Resorption
03/2017 - 06/2000
5Osteoporosis
01/2017 - 06/2009
3Neoplasms (Cancer)
01/2019 - 06/2000
3Inflammation (Inflammations)
03/2017 - 07/2003
3Hypertrophy
01/2013 - 01/2011
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2013 - 01/2011
3Metabolic Bone Diseases (Osteopenia)
07/2012 - 05/2009
2Carcinogenesis
01/2019 - 01/2017
2Osteosarcoma (Osteogenic Sarcoma)
06/2013 - 06/2000
2Proteinuria
01/2013 - 01/2011
2Atherosclerotic Plaque (Atheroma)
06/2008 - 07/2003
2Carcinoma (Carcinomatosis)
01/2008 - 03/2007
2Fibrosis (Cirrhosis)
06/2006 - 06/2002
1Colorectal Neoplasms (Colorectal Cancer)
03/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Osteoarthritis
05/2016
1Chronic Kidney Failure (Chronic Renal Failure)
05/2013
1Hypoxia (Hypoxemia)
01/2012
1Wounds and Injuries (Trauma)
10/2011
1Hypertriglyceridemia
05/2011
1Hyperglycemia
05/2011
1Hypercholesterolemia
05/2011
1Body Weight (Weight, Body)
05/2011
1Bone Diseases (Bone Disease)
04/2010
1Glucose Intolerance
06/2009
1Type 2 Diabetes Mellitus (MODY)
06/2009
1Ureteral Obstruction
08/2008
1Margins of Excision
01/2008
1Cardiovascular Diseases (Cardiovascular Disease)
10/2007
1Renal Insufficiency (Renal Failure)
01/2004
1Atherosclerosis
07/2003
1Brain Diseases (Brain Disorder)
07/2003

Drug/Important Bio-Agent (IBA)

19Parathyroid Hormone-Related ProteinIBA
04/2016 - 06/2000
5Parathyroid Hormone (Parathormone)IBA
04/2016 - 08/2002
4CytokinesIBA
05/2010 - 08/2002
3Insulin (Novolin)FDA Link
03/2017 - 06/2009
3parathyroid hormone-related protein (107-111)IBA
06/2013 - 10/2011
3Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA
05/2012 - 06/2000
3Proteins (Proteins, Gene)FDA Link
05/2012 - 08/2002
2Biological ProductsIBA
03/2017 - 01/2017
2Metformin (Glucophage)FDA LinkGeneric
03/2017 - 01/2017
2CateninsIBA
03/2017 - 04/2013
2Streptozocin (Streptozotocin)FDA Link
03/2017 - 01/2017
2Peptides (Polypeptides)IBA
05/2013 - 04/2010
2Cell Cycle ProteinsIBA
01/2013 - 05/2012
2Glucose (Dextrose)FDA LinkGeneric
05/2012 - 06/2009
2parathyroid hormone-related protein (107-139)IBA
04/2012 - 06/2000
2Glucagon-Like Peptide 1 (GLP 1)IBA
05/2011 - 06/2009
2LigandsIBA
01/2008 - 03/2007
1Cisplatin (Platino)FDA LinkGeneric
10/2019
1A-factor (Streptomyces)IBA
01/2019
1ProteomeIBA
01/2019
1IronIBA
03/2017
1Parathyroid Hormone ReceptorsIBA
01/2017
1MicroRNAs (MicroRNA)IBA
05/2016
1Bone Density Conservation AgentsIBA
05/2013
1OsteopontinIBA
05/2013
1Differentiation AntigensIBA
04/2013
1Angiotensin IIIBA
01/2013
1MethylprednisoloneFDA LinkGeneric
07/2012
1Cyclin D1IBA
05/2012
1Cyclin EIBA
05/2012
1Cyclin-Dependent Kinase Inhibitor p27IBA
05/2012
1Oxygen (Dioxygen)IBA
01/2012
1Exenatide (Byetta)FDA Link
05/2011
1Glucagon-Like Peptide 2IBA
06/2009
1Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
06/2009
1Hormones (Hormone)IBA
06/2009
1Anabolic AgentsIBA
06/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2008
1Messenger RNA (mRNA)IBA
08/2008
1oxidized low density lipoproteinIBA
06/2008
1RANK LigandIBA
01/2008
1Prostate-Specific Antigen (Semenogelase)IBA
01/2008
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
01/2008
1OsteoprotegerinIBA
03/2007
1Folic Acid (Vitamin M)FDA LinkGeneric
06/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2004
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2004
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2003
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2003
1NF-kappa B (NF-kB)IBA
08/2002
1Interleukin-6 (Interleukin 6)IBA
08/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2000
1parathyroid hormone-related protein (1-34)IBA
06/2000

Therapy/Procedure

5Therapeutics
01/2017 - 04/2010